Latest Interesting Articles
News from Industry
Boston Scientific Receives FDA Approval for WATCHMAN™ Left Atrial Appendage Closure Device
First-Of-Its-Kind Alternative to Long-Term Warfarin Therapy for Stroke Risk Reduction in Patients with Non-Valvular Atrial Fibrillation.

(Source: http://news.bostonscientific.com/2015-03-13-Boston-Scientific-Receives-FDA-Approval-for-WATCHMAN-Left-Atrial-Appendage-Closure-Device)
|
|
|